LIN SHAO-LEE (CHIEF EXECUTIVE OFFICER) sold 1.6% of their position (11.09K shares) of CUE BIOPHARMA, INC. on the open market
Open‑market sale worth $305.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/15/2026ACC: 0001725092-26-000019
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2026
-11.09K
Net shares
Net seller
$305.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
11.09K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−10K
Price / share
$27.50
Trade value
$275K
% of position
1.4%
10/12/2026
706K→696K
Common Stock
Direct
Shares
−1.09K
Price / share
$28.05
Trade value
$30.49K
% of position
0.2%
10/12/2026
696K→694.91K
Total
Net shares
−11.09K
Net value
-$305.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/12/2026 | S · Sale | −10K | $27.50 | $275K | 1.4% | 706K | 696K |
| Common Stock Direct | 10/12/2026 | S · Sale | −1.09K | $28.05 | $30.49K | 0.2% | 696K | 694.91K |
| Total | −11.09K | -$305.49K | ||||||
Derivative Transactions0
No derivative transactions reported